Biotech

All Articles

Zephyrm looks for Hong Kong IPO to fund stage 3 tissue treatment trials

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, submitting (PDF) for an...

Frazier Life Sciences gets $630M for tiny, mid-cap biotechs

.Frazier Daily life Sciences has sourced an even further $630 million for its fund focused on tiny a...

GigaGen garners around $135M BARDA dollars to beat botulism

.Antibody aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is actually ramping up its ...

GPCR firm Septerna declare IPO on durability of preclinical data

.Septerna will learn just how a biotech without "any sort of purposeful professional records" meals ...

Kurma shuts to begin with $154M haul for biggest biotech fund as yet

.International VC company Kurma Partners has unveiled its own latest biotech fund, along with 140 th...

Prothena ensures one officer while an additional places-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings...

Editas cashes in on Tip Cas9 licensing civil liberties for $57M

.Versus the backdrop of a Cas9 license fight that declines to die, Editas Medication is cashing in a...

Ultragenyx tweaks gene treatment dosing to call up efficacy

.A minority of patients taking Ultragenyx Drug's Wilson condition gene treatment UX701 have come off...

Biopharma discharge cost maintains in Q3: Fierce Biotech study

.As summer warmth turns to cool down winds, hopes that this year would certainly deliver widespread ...

J &amp J goes down stage 2 dengue applicant in most recent switch coming from vaccinations

.Johnson &amp Johnson's deprioritization of its own transmittable condition pipe has actually stated...